Optimizing palliative chemotherapy for advanced invasive mucinous adenocarcinoma of the lung.
Yoon Jung JangDong-Gon HyunChang-Min ChoiDae Ho LeeSang-We KimShinkyo YoonWoo Sung KimWonjun JiJae Cheol LeePublished in: BMC cancer (2021)
This study suggests that immunotherapy for patients with advanced IMA may provide favorable outcomes than other chemotherapy options.